The Swedish biotech Medivir AB has appointed Magnus Christensen as its new chief financial officer, effective 12 August. In this role he will be responsible for investor relations as well as leading the day-to-day operations within the departments of finance, information technology and human resources. He joins Medivir from O’Learys Trademark AB where he was also CFO.
Medivir announced the appointment on 29 April 2019.
Copyright 2019 Evernow Publishing Ltd